BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18971789)

  • 1. Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.
    Vad NM; Yount G; Moridani MY
    Melanoma Res; 2008 Dec; 18(6):386-99. PubMed ID: 18971789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines.
    Vad NM; Yount G; Moore D; Weidanz J; Moridani MY
    J Pharm Sci; 2009 Apr; 98(4):1409-25. PubMed ID: 18759348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines.
    Kudugunti SK; Vad NM; Whiteside AJ; Naik BU; Yusuf MA; Srivenugopal KS; Moridani MY
    Chem Biol Interact; 2010 Oct; 188(1):1-14. PubMed ID: 20685355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.
    Vad NM; Kandala PK; Srivastava SK; Moridani MY
    Chem Biol Interact; 2010 Feb; 183(3):462-71. PubMed ID: 19944085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic bioactivation and toxicity of ethyl 4-hydroxybenzoate in human SK-MEL-28 melanoma cells.
    Vad NM; Shaik IH; Mehvar R; Moridani MY
    J Pharm Sci; 2008 May; 97(5):1934-45. PubMed ID: 17847068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.
    Vad NM; Kudugunti SK; Graber D; Bailey N; Srivenugopal K; Moridani MY
    Int J Oncol; 2009 Jul; 35(1):193-204. PubMed ID: 19513568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-F0 melanoma cells.
    Moridani MY
    Cancer Lett; 2006 Nov; 243(2):235-45. PubMed ID: 16427188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of caffeic acid phenethyl ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice.
    Kudugunti SK; Vad NM; Ekogbo E; Moridani MY
    Invest New Drugs; 2011 Feb; 29(1):52-62. PubMed ID: 19844662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivation of luteolin by tyrosinase selectively inhibits glutathione S-transferase.
    Balyan R; Kudugunti SK; Hamad HA; Yousef MS; Moridani MY
    Chem Biol Interact; 2015 Oct; 240():208-18. PubMed ID: 26279214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase.
    Kudugunti SK; Thorsheim H; Yousef MS; Guan L; Moridani MY
    Chem Biol Interact; 2011 Jul; 192(3):243-56. PubMed ID: 21458432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.
    Fecker LF; Geilen CC; Hossini AM; Schwarz C; Fechner H; Bartlett DL; Orfanos CE; Eberle J
    J Invest Dermatol; 2005 Jan; 124(1):221-8. PubMed ID: 15654977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas.
    Hara H; Lee MH; Chen H; Luo D; Jimbow K
    J Invest Dermatol; 1994 Apr; 102(4):495-500. PubMed ID: 8151127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural toxicity relationship of 4-alkoxyphenols' cytotoxicity towards murine B16-F0 melanoma cell line.
    Moridani MY; Moore M; Bartsch RA; Yang Y; Heibati-Sadati S
    J Pharm Pharm Sci; 2005 Aug; 8(2):348-60. PubMed ID: 16124947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of tyrosinase expression by acetylsalicylic acid in murine B16 melanoma.
    Sato K; Takahashi H; Iraha R; Toriyama M
    Biol Pharm Bull; 2008 Jan; 31(1):33-7. PubMed ID: 18175938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.
    Vad NM; Kudugunti SK; Wang H; Bhat GJ; Moridani MY
    Tumour Biol; 2014 May; 35(5):4967-76. PubMed ID: 24492939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells.
    Raza H; John A; Benedict S
    Eur J Pharmacol; 2011 Oct; 668(1-2):15-24. PubMed ID: 21722632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase.
    Thangasamy T; Sittadjody S; Lanza-Jacoby S; Wachsberger PR; Limesand KH; Burd R
    Nutr Cancer; 2007; 59(2):258-68. PubMed ID: 18001220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
    Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
    J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.